↓ Skip to main content

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era

Overview of attention for article published in BMC Musculoskeletal Disorders, September 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
Published in
BMC Musculoskeletal Disorders, September 2014
DOI 10.1186/1471-2474-15-289
Pubmed ID
Authors

Glenn Haugeberg, Knut Bjørn Helgetveit, Øystein Førre, Torhild Garen, Hege Sommerseth, Anne Prøven

Abstract

Osteoporosis is a well-known extra articular manifestation in rheumatoid arthritis (RA). Biologic disease modifying anti rheumatic drugs (DMARDs) has been shown to be superior to synthetic DMARDs to reduce bone destruction including generalized bone loss in RA. Our aim was to study short- and long term changes in hip and spine bone mineral density (BMD) in early RA patients treated during the first decade with available biologic DMARDs.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Colombia 1 2%
Canada 1 2%
Unknown 44 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 25%
Student > Master 6 13%
Other 5 10%
Student > Doctoral Student 4 8%
Student > Bachelor 4 8%
Other 9 19%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 22 46%
Nursing and Health Professions 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Environmental Science 1 2%
Other 5 10%
Unknown 10 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2014.
All research outputs
#6,487,026
of 11,331,318 outputs
Outputs from BMC Musculoskeletal Disorders
#1,216
of 2,325 outputs
Outputs of similar age
#84,279
of 195,339 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#42
of 104 outputs
Altmetric has tracked 11,331,318 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,325 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,339 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.